| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.063 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.056 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.059 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |